Goldman to invest $37 mln in Venus Medtech

Goldman Sachs is investing $37 million in Venus Medtech (Hangzhou) Inc. Venus Medtech, of Hangzhou, China, is developing a transcatheter cardiac valve. Prior investors include Qiming Venture Partners, Sequoia Capital China and Dinova Venture Capital.

North AmericaUSBriefs